Treat your Patients with the Advantage of Natural Tissue Engineering.®


WoundEx® Membrane Lower Extremity Wound Study Highlights


WoundEx® Closure Rate


WoundEx® Membrane - The Original Viable Amniotic Membrane


WoundEx® Membrane is a FastActing® dehydrated amniotic membrane skin substitute, available in thin amnion-only WoundEx®45 and thick chorion-based WoundEx®200.


WoundEx® Membrane Product Benefits


Provides a native human placental BioActive® ECM

orangeicons_Artboard 44 copy.png

Various sizes minimize graft waste & cost


Omnidirectional (apply in any direction)


Adheres to wound bed without fixation


FastActing® Technology improves biologic response


Layers of the Placental Membranes


Ordering Information

Screen Shot 2017-11-02 at 11.41.06 AM.png

HCPCS code: Q4163




WoundEx® Flow - The Original Flowable Tissue Matrix™

woundmem copy.jpg

WoundEx® Flow is a flowable human placental connective tissue matrix skin substitute. It is provided as a concentrated fluid in the vial, and can be extended with saline or anesthetic to provide greater coverage throughout the entire wound.


WoundEx Flow® Product Benefits


Provides a native human placental BioActive® ECM


Fluid provides ideal coverage throughout the wound


Stays in the tissue to avoid patient compliance issues


ExCellerate® Technology for optimal biologic response


Room temperature storage


Ordering Information

Screen Shot 2017-11-02 at 11.57.59 AM.png

HCPCS code: Q4162

References on file

NOTE Skye Biologics, Inc. make no claims concerning the biological properties of any product or potential outcomes as a result of the use of any product. Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own physician or other medical professional. The results reported may not necessarily occur in all individuals. Skye Biologics is providing this site and its contents on an “as is” basis and makes no representations or warranties of any kind with respect to this site or its contents. All tissues have been collected, processed, stored and distributed in compliance with FDA regulations governing HCT/Ps.